To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
8,708 Current news from the industry pharma
rss |
You can refine your search further. Select from the filter options on the left to narrow down your results. |
First generation of real microbiome-based therapeutics
Microbiome therapeutics biotech mbiomics raises EUR 13 million in first closing of Series A round
28-Mar-2023
mbiomics GmbH, a pioneering microbiome biotech company developing the first generation of effective microbiome-based therapeutics announced the first closing of EUR13 million (US$ 15 million) of a series A financing round led by MIG Capital. High-Tech Gründerfonds and Bayern Kapital joined the ...
Evotec receives US$ 6.6 m grant for drug discovery in tuberculosis
24-Mar-2023
Evotec SE announced that the Company has received a US$ 6.6 m grant from The Bill & Melinda Gates Foundation for drug discovery in tuberculosis (“TB”). The grant is the second award from the foundation to Evotec supporting TB drug discovery, and allows the Company to progress a portfolio of TB ...
Transparency for clinical trials
Transparency of study results in a public dashboard
24-Mar-2023
Clinical trials are the “backbone of evidence-based medicine”: This is where new drugs and treatments are tested on humans for the first time. The results of such trials are therefore highly relevant. But unfortunately many clinical trial results from German universities are not published at all ...
New checkpoint antibody against cancer
BioNTech and OncoC4 announce strategic collaboration
22-Mar-2023
BioNTech SE and OncoC4, Inc., a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel biologicals for cancer treatment, announced that they have entered into an exclusive worldwide license and collaboration agreement to develop and commercialize OncoC4’s ...
Innovative technologies remove pharmaceutical residues from wastewater
21-Mar-2023
Every year on 22 March, World Water Day reminds us of the importance of one of the most important resources of life. Almost two-thirds of our planet is covered with water, but not even three percent is drinkable freshwater. Every day, large quantities of chemicals enter our waters and endanger ...
Successful exit: Miltenyi Biotec acquires biosensor company lino Biotech
21-Mar-2023
lino Biotech, a biosensor company and the world’s only provider of Focal Molography®, announced it has been acquired by Miltenyi Biotec, a global biotech company based in Germany, on February 22, 2023. Since its founding in 2020, lino Biotech has made significant advances in developing new ...
Known active ingredient as new drug candidate against “monkeypox”
21-Mar-2023
Mpox – previously known as "monkeypox" – is currently spreading worldwide. An international research team from Goethe University and the University of Kent has now identified a compound that could help fight the disease. Their study has been published in the “Journal of Medical ...
Insilico Medicine brings AI-powered “ChatPandaGPT” to its target discovery platform
A revolution in drug discovery thanks to a new chat assistant?
16-Mar-2023
Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-powered drug discovery company, has integrated advanced AI chat functionality based on recent advances in large language models into its PandaOmics platform. The new feature, “ChatPandaGPT,” enables researchers to have ...
Yokogawa Acquires Fluence Analytics, a Pioneer in Digitalizing the Monitoring of Polymerization Reaction Processes
Enabling continuous real-time monitoring of polymers and biopolymers: Gamechanger for the polymer and biopharmaceutical industry
14-Mar-2023
Yokogawa Electric Corporation announces the acquisition of Fluence Analytics, Inc., a US-based startup that provides real-time analytics solutions to polymer and biopharmaceutical companies worldwide. Since signing investment and collaboration agreements in August 2021, the two companies have ...
Artificial intelligence could improve therapy for lymphoma
09-Mar-2023
Hodgkin’s lymphoma, a type of lymph node cancer, requires chemotherapy and radiation therapy that can be very stressful for patients. A research group in Vienna is working on a method to predict the course of the disease with the help of artificial intelligence algorithms. This would facilitate a ...
